US RNA Analysis Market to Reach USD 15.59 Billion by 2032; MarkNtel Advisors Reviews AI-Driven Transcriptomics and Precision Oncology Advancements

MarkNtel Advisors has published a comprehensive market research report on the US RNA Analysis Market, providing an in-depth assessment of product categories, analytical technologies, clinical applications, end-user landscape, competitive environment, and emerging growth opportunities. The report offers strategic insights into RNA sequencing, molecular diagnostics, precision medicine, pharmaceutical research, and transcriptomic innovations supporting decision-making across the life sciences industry. 

The US RNA analysis market is projected to grow at a CAGR of 11.37% during 2026-2032. Market expansion is driven by increasing adoption of precision oncology, rising demand for RNA-based molecular diagnostics, expanding pharmaceutical investment in RNA therapeutics, growing genomic research funding, and continuous advancements in sequencing technologies and bioinformatics platforms. 

Reagents & consumables represent the leading product segment in the US RNA analysis market, accounting for approximately 55% of the market in 2026. Their dominance is supported by recurring laboratory demand across RNA extraction, sequencing, gene expression analysis, biomarker discovery, and clinical research applications, making consumables an essential component of every RNA analysis workflow. 

The US RNA Analysis Market Highlights

• Study Period: 2026-32
• Base Year: 2025    
• Market Size (2025): USD 7.77 Billion                     
• Market Size (2026): USD 8.17 Billion                       
• Market Size (2032): USD 15.59 Billion                            
• Projected CAGR (2026–2032): 11.37%                      
• By Product: Reagents & Consumables (55%)       
• By Technology: Sequencing Technologies (46%) 

Get a FREE PDF Sample of the Report: https://www.marknteladvisors.com/query/request-sample/us-rna-analysis-market-report.html (Explore how precision oncology, RNA sequencing, artificial intelligence, transcriptomic research, companion diagnostics, and next-generation genomic technologies are transforming RNA analysis across the United States.) 

Key Market Trends

• Artificial Intelligence Enhancing RNA Sequencing Data Interpretation: AI and machine learning technologies are becoming integral to transcriptomic analysis by improving gene expression profiling, biomarker identification, splice variant detection, and disease prediction. The growing integration of AI into RNA sequencing workflows is enabling faster and more accurate interpretation of complex genomic datasets across research and clinical laboratories. 
• Growing Adoption of RNA Sequencing in Precision Oncology: Healthcare providers and pharmaceutical companies are increasingly utilizing RNA sequencing to support companion diagnostics, tumor profiling, biomarker discovery, and personalized treatment selection. The expansion of RNA-based diagnostic assays and targeted cancer therapies continues to strengthen demand for advanced RNA analysis platforms. 

Key Market Challenge

• Strengthening Genomic Data Security Requirements Increasing Compliance Demands: New regulations governing genomic data protection and cross-border data sharing are requiring laboratories to strengthen compliance, cybersecurity, and data governance infrastructure. These evolving requirements are encouraging greater investment in secure domestic RNA analysis platforms while increasing operational complexity for research organizations. 

Major Companies in the US RNA Analysis Market 

• Thermo Fisher Scientific Inc.
• Illumina, Inc.
• Agilent Technologies, Inc.
• Bio-Rad Laboratories, Inc.
• 10x Genomics, Inc.
• Pacific Biosciences of California, Inc.
• Standard BioTools Inc.
• QIAGEN N.V.
• F. Hoffmann-La Roche Ltd.
• Oxford Nanopore Technologies plc

US RNA Analysis Market Scope:

• By Product: Reagents & Consumables, Instruments, Software, Services
• By Technology: Polymerase Chain Reaction (PCR), Microarrays, Sequencing Technologies, RNA Interference (RNAi)
• By Application: Drug Discovery, Clinical Diagnostics, Toxicogenomics, Comparative Transcriptomics
• By End User: Pharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Centers, Academic & Research Institutes, Contract Research Organizations (CROs)

Browse More Reports:

• Human Longevity Market: The market is projected to grow at a CAGR of around 16.8% during 2026-2032. 
• India Surgical Instruments Market: The market is projected to grow at a CAGR of around 8.54% during 2026-2032. 
• US Surgical Instruments Market: The market is projected to grow at a CAGR of around 10.26% during 2026-2032. 
• China Proteomics Market: The market is projected to grow at a CAGR of around 11.27% during 2026-2032. 
• Global Artificial Intelligence in Precision Medicine Market: The market is projected to grow at a CAGR of around 31.35% during 2026-2032. 

About MarkNtel Advisors

MarkNtel Advisors is a global market research and consulting firm delivering reliable industry intelligence across healthcare, technology, energy, manufacturing, and several other sectors. Through extensive primary research, market forecasting, competitive analysis, and strategic consulting, the firm enables organizations to identify emerging opportunities, evaluate market dynamics, and make informed business decisions supported by actionable, data-driven insights. 

Contact US:

MarkNtel Advisors

Office No.109, H-159, Sector 63, Noida, Uttar Pradesh – 201301, India

Contact No: +91 87199 99009

Email: sales@marknteladvisors.com

Website: marknteladvisors.com